QDEL: QuidelOrtho Corp.
About
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Current Value
$36.981 Year Return
Current Value
$36.981 Year Return
Key Details
Market Cap
$2.59B
P/E Ratio
-1.38
1Y Stock Return
-44.25%
1Y Revenue Growth
-9.66%
Dividend Yield
0.00%
Price to Book
0.8
Strategies that include QDEL
Stock's related to QDEL
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IMMR | 39.92% | $276.60M | +33.49% | 2.09% |
| CIM | 33.74% | $1.19B | -2.45% | 6.42% |
| CAE | 32.95% | $7.16B | +7.26% | 0.00% |
| AKAM | 32.67% | $13.12B | -22.78% | 0.00% |
| PODD | 32.00% | $18.38B | +44.49% | 0.00% |
| CC | 31.06% | $2.82B | -27.44% | 5.31% |
| KHC | 30.60% | $36.98B | -10.45% | 5.23% |
| CCS | 29.88% | $2.69B | +20.00% | 1.19% |
| RC | 29.30% | $1.22B | -27.41% | 15.95% |
| OSUR | 29.14% | $287.93M | -46.24% | 0.00% |
| GRAL | 28.90% | $459.22M | -13.00% | 0.00% |
| SONY | 28.68% | $114.13B | +9.00% | 1.49% |
| GNL | 28.63% | $1.69B | -16.46% | 16.20% |
| GPRO | 28.48% | $179.52M | -67.23% | 0.00% |
| APPS | 28.37% | $125.51M | -75.85% | 0.00% |
| ZD | 28.35% | $2.37B | -14.73% | 0.00% |
| PDM | 27.91% | $1.17B | +53.51% | 5.34% |
| UE | 27.81% | $2.93B | +40.88% | 2.86% |
| HBI | 27.75% | $2.92B | +111.51% | 0.00% |
| TXG | 27.73% | $1.64B | -68.30% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CDNS | -<0.01% | $82.18B | +10.81% | 0.00% |
| AGX | 0.01% | $2.01B | +224.91% | 0.85% |
| AMC | 0.01% | $1.63B | -34.74% | 0.00% |
| PDD | -0.01% | $163.43B | +0.29% | 0.00% |
| LFWD | 0.02% | $16.21M | -63.99% | 0.00% |
| GNE | 0.02% | $425.67M | -37.42% | 1.92% |
| KLAC | -0.04% | $82.35B | +11.80% | 0.98% |
| TNET | 0.04% | $4.41B | -19.81% | 0.84% |
| ETN | 0.04% | $143.73B | +60.21% | 1.02% |
| CNI | 0.04% | $67.10B | -6.77% | 2.29% |
| OCSL | 0.04% | - | - | 14.23% |
| CHX | -0.07% | $5.82B | +4.16% | 1.21% |
| CCJ | 0.07% | $25.01B | +28.34% | 0.15% |
| MDB | 0.08% | $21.36B | -28.69% | 0.00% |
| ANET | 0.09% | $118.95B | +75.41% | 0.00% |
| MG | 0.15% | $282.81M | +42.06% | 0.00% |
| HES | -0.21% | $45.06B | +1.32% | 1.24% |
| SPOT | 0.22% | $90.80B | +159.59% | 0.00% |
| VNT | -0.22% | $5.57B | +11.08% | 0.27% |
| HOOD | 0.22% | $31.15B | +341.60% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| COGT | -26.28% | $1.00B | +31.69% | 0.00% |
| LYFT | -24.41% | $6.87B | +59.63% | 0.00% |
| HCSG | -24.15% | $832.59M | +14.29% | 0.00% |
| UBER | -19.62% | $145.57B | +26.03% | 0.00% |
| GYRE | -19.44% | $1.21B | +1.49% | 0.00% |
| PGR | -18.47% | $149.10B | +57.29% | 0.45% |
| ALSN | -16.21% | $10.05B | +115.86% | 0.86% |
| MCK | -15.89% | $78.15B | +35.51% | 0.42% |
| VHC | -15.62% | $19.06M | -38.36% | 0.00% |
| PRPH | -15.41% | $18.14M | -82.61% | 0.00% |
| REZI | -14.96% | $3.84B | +62.64% | 0.00% |
| WCN | -13.28% | $48.39B | +42.47% | 0.62% |
| CAMT | -13.26% | $3.40B | +16.39% | 0.00% |
| CME | -13.20% | $82.76B | +9.21% | 1.98% |
| SMWB | -12.17% | $1.01B | +134.25% | 0.00% |
| WRB | -11.98% | $22.94B | +29.98% | 0.69% |
| CRWD | -11.78% | $86.61B | +69.05% | 0.00% |
| PSN | -11.51% | $10.03B | +50.06% | 0.00% |
| UFCS | -11.42% | $696.15M | +35.19% | 2.34% |
| AME | -10.64% | $44.75B | +24.49% | 0.56% |
ETF's related to QDEL
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FXH | 35.96% | $1.15B | 0.62% |
| XHE | 35.95% | $213.41M | 0.35% |
| RSPH | 32.52% | $885.96M | 0.4% |
| IHI | 32.31% | $4.91B | 0.4% |
| KBWY | 31.11% | $246.93M | 0.35% |
| PINK | 29.83% | $161.15M | 0.5% |
| XSHD | 29.75% | $54.49M | 0.3% |
| EDOC | 29.62% | $40.86M | 0.68% |
| SRVR | 29.40% | $448.44M | 0.55% |
| EZM | 29.39% | $823.84M | 0.38% |
| FAN | 29.19% | $163.64M | 0.6% |
| FBT | 28.97% | $1.11B | 0.56% |
| RDIV | 28.71% | $842.58M | 0.39% |
| MOAT | 28.65% | $15.73B | 0.46% |
| RIET | 28.31% | $88.96M | 0.5% |
| RWO | 28.25% | $1.18B | 0.5% |
| FHLC | 28.21% | $2.73B | 0.084% |
| ARKG | 28.16% | $1.13B | 0.75% |
| VHT | 28.15% | $17.06B | 0.1% |
| LVHD | 28.04% | $560.70M | 0.27% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| WINN | -0.12% | $620.54M | 0.57% |
| TBLL | 0.14% | $1.92B | 0.08% |
| SGOV | -0.20% | $27.53B | 0.09% |
| URNJ | -0.21% | $283.55M | 0.8% |
| FFOG | -0.23% | $118.40M | 0.55% |
| SMH | 0.27% | $23.66B | 0.35% |
| SPMO | -0.45% | $3.92B | 0.13% |
| SEIX | 0.50% | $268.81M | 0.62% |
| SHV | 0.71% | $18.13B | 0.15% |
| CONY | 0.80% | $1.07B | 1.01% |
| BOXX | 0.85% | $4.43B | 0.1949% |
| TAIL | 1.01% | $67.98M | 0.59% |
| FEPI | 1.22% | $406.41M | 0.65% |
| MTUM | -1.32% | $13.13B | 0.15% |
| URNM | -1.35% | $1.61B | 0.75% |
| BILZ | 1.44% | $563.02M | 0.14% |
| IAK | 1.64% | $760.79M | 0.39% |
| URA | 1.81% | $3.55B | 0.69% |
| IGM | 1.82% | $5.60B | 0.41% |
| FLOT | 1.82% | $7.31B | 0.15% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -17.69% | $388.04M | 1.43% |
| USDU | -16.48% | $201.97M | 0.5% |
| CTA | -14.56% | $350.27M | 0.78% |
| UUP | -14.40% | $309.25M | 0.77% |
| EQLS | -12.30% | $76.08M | 1% |
| VIXY | -8.70% | $195.31M | 0.85% |
| KMLM | -7.12% | $353.87M | 0.9% |
| DBMF | -6.43% | $1.02B | 0.85% |
| MINT | -6.17% | $11.62B | 0.35% |
| CANE | -5.64% | $17.72M | 0.29% |
| KCCA | -4.94% | $220.51M | 0.87% |
| FMF | -4.90% | $244.61M | 0.95% |
| AMDY | -4.85% | $144.24M | 0.99% |
| HIGH | -4.55% | $302.78M | 0.51% |
| BLCN | -4.55% | $70.20M | 0.68% |
| AGZD | -4.44% | $142.76M | 0.23% |
| FLTR | -4.42% | $1.79B | 0.14% |
| FTLS | -3.48% | $1.62B | 1.46% |
| FBY | -2.87% | $127.69M | 0.99% |
| URNM | -1.35% | $1.61B | 0.75% |
News
Yahoo
SAN DIEGO, November 20, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the pricing of the previously announced underwritten secondary offering (the "Offering") by Carlyle Partners VI Cayman Holdings, L.P. (the "Selling Stockholder") of 8,260,183 shares of the Company’s common stock ("Common Stock").
Yahoo
SAN DIEGO, November 19, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the launch of an underwritten secondary offering (the "Offering") by Carlyle Partners VI Cayman Holdings, L.P. (the "Selling Stockholder") of 8,260,183 shares of the Company’s common stock ("Common Stock").
Finnhub
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation breached their...
Yahoo
QuidelOrtho ( NASDAQ:QDEL ) Third Quarter 2024 Results Key Financial Results Revenue: US$727.1m (down 2.3% from 3Q...
Yahoo
QuidelOrtho Corp (QDEL) reports solid progress in business improvements despite revenue decline and external headwinds.
Yahoo
SAN DIEGO, November 07, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the third quarter ended September 29, 2024.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.